<?xml version="1.0" encoding="UTF-8"?>
<p>Currently, healthcare organizations and other businesses are formulating plans to bring individuals back on‐site, despite the lingering threat of COVID‐19. Various strategies have been proposed to safely do this, some involving widespread testing of asymptomatic individuals. The data presented here as well as recent reports argue that the interpretation of widespread testing may be complicated by persistent PCR positivity, especially in individuals who were clinically asymptomatic and never diagnosed originally.
 <xref rid="trf16015-bib-0015" ref-type="ref">
  <sup>15</sup>
 </xref> It also raises the possibility that individuals who appear to be re‐infected were actually just persistently positive.
 <xref rid="trf16015-bib-0016" ref-type="ref">
  <sup>16</sup>
 </xref> Ultimately, the issue becomes a practical one. For example, if a negative NP swab PCR is needed for clearance for surgery, how long should a patient be made to wait if they have persistently positive NP swabs?
</p>
